Characterisation of liver fat in the UK Biobank cohort
Open accessThe DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease and the risk of progression to steatohepatitis, cirrhosis and hepatocellular carcinoma have been identified as major public health concerns. We have demonstrated the feasibility and potential value of measuring liver fat content by magnetic resonance imaging (MRI) in a large population in this study of 4,949 participants (aged 45-73 years) in the UK Biobank imaging enhancement. Despite requirements for only a single (≤3min) scan of each subject, liver fat was able to be measured as the MRI proton density fat fraction (PDFF) with an overall success rate of 96.4%. The overall hepatic fat distribution was centred between 1-2%, and was highly skewed towards higher fat content. The mean PDFF was 3.91%, and median 2.11%. Analysis of PDFF in conjunction with other data fields available from the UK Biobank Resource showed associations of increased liver fat with greater age, BMI, weight gain, high blood pressure and Type 2 diabetes. Subjects with BMI less than 25 kg/m2 had a low risk (5%) of high liver fat (PDFF > 5.5%), whereas in the higher BMI population (>30 kg/m2) the prevalence of high liver fat was approximately 1 in 3. These data suggest that population screening to identify people with high PDFF is possible and could be cost effective. MRI based PDFF is an effective method for this. Finally, although cross sectional, this study suggests the utility of the PDFF measurement within UK Biobank, particularly for applications to elucidating risk factors through associations with prospectively acquired data on clinical outcomes of liver diseases, including non-alcoholic fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding is consistent with a ‘floor effect’ for hepatic fat, which is unlikely to be reduced below the median of 2.1% observed in the large UK Biobank study27.”
From Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., Subbarayan, S., Webb, A., Hecht, J., & Cusi, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2739 · Cited by 200
RetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 2×
“A prospective study of 4949 subjects from the UK Biobank imaging enhancement protocol [27,28] acquired between August 2014 and October 2015.”
BackgroundMethodSelf-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“8% in different regions [4– 6], while prevalence in the USA has been estimated to be between 30% [7,8] and 46% [9].”
Background(2013) · Gastroenterology Research · doi:10.1053/j · Cited by 2,759
A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems
Hand, D. J., & Till, R. J. (2001) · Machine Learning · doi:10.1023/a:1010920819831 · Cited by 2,276 · cited 1×
“2 years [17] with 7% progressing to HCC in 6.”
BackgroundSimple proton spectroscopic imaging.
Dixon, W. T. (1984) · Radiology · doi:10.1148/radiology.153.1.6089263 · Cited by 2,276
Cited by
Littlejohns, T. J., Holliday, J., Gibson, L. M., Garratt, S., Oesingmann, N., Alfaro-Almagro, F., Bell, J. D., Boultwood, C., Collins, R., Conroy, M. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15948-9 · Cited by 812
Self-citationChanging epidemiology, global trends and implications for outcomes of NAFLD
Wong, V. W.-S., Ekstedt, M., Wong, G. L.-H., & Hagström, H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.036 · Cited by 765
Genetics of 35 blood and urine biomarkers in the UK Biobank
Sinnott-Armstrong, N., Tanigawa, Y., Amar, D., Mars, N., Benner, C., Aguirre, M., Venkataraman, G. R., Wainberg, M., Ollila, H. M., Kiiskinen, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00757-z · Cited by 744
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Magkos, F., Hjorth, M. F., & Astrup, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0381-5 · Cited by 469
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
Sanyal, A. J., Kaplan, L. M., Frias, J. P., Brouwers, B., Wu, Q., Thomas, M. K., Harris, C., Schloot, N. C., Du, Y., Mather, K. J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03018-2 · Cited by 315
Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease
Åberg, F., Byrne, C. D., Pirola, C. J., Männistö, V., & Sookoian, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.030 · Cited by 307
Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning
Liu, Y., Basty, N., Whitcher, B., Bell, J. D., Sorokin, E. P., van Bruggen, N., Thomas, E. L., & Cule, M. (2021) · eLife · doi:10.7554/elife.65554 · Cited by 274
Self-citationMultiomics study of nonalcoholic fatty liver disease
Sveinbjornsson, G., Ulfarsson, M. O., Thorolfsdottir, R. B., Jonsson, B. A., Einarsson, E., Gunnlaugsson, G., Rognvaldsson, S., Arnar, D. O., Baldvinsson, M., Bjarnason, R. G., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01199-5 · Cited by 236
Ghodsian, N., Abner, E., Emdin, C. A., Gobeil, É., Taba, N., Haas, M. E., Perrot, N., Manikpurage, H. D., Gagnon, É., Bourgault, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100437 · Cited by 229
Raverdy, V., Tavaglione, F., Chatelain, E., Lassailly, G., De Vincentis, A., Vespasiani-Gentilucci, U., Qadri, S. F., Caiazzo, R., Verkindt, H., Saponaro, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03283-1 · Cited by 169
Parisinos, C. A., Wilman, H. R., Thomas, E. L., Kelly, M., Nicholls, R. C., McGonigle, J., Neubauer, S., Hingorani, A. D., Patel, R. S., Hemingway, H., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.032 · Cited by 149
Self-citationDevelopment and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
Tavaglione, F., Jamialahmadi, O., Vincentis, A. D., Qadri, S. U., Mowlaei, M. E., Mancina, R. M., Ciociola, E., Carotti, S., Perrone, G., Bruni, V., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.03.044 · Cited by 133
Machine learning enables new insights into genetic contributions to liver fat accumulation
Haas, M. E., Pirruccello, J. P., Friedman, S. N., Wang, M., Emdin, C. A., Ajmera, V. H., Simon, T. G., Homburger, J. R., Guo, X., Budoff, M., et al. (2021) · Cell Genomics · doi:10.1016/j.xgen.2021.100066 · Cited by 118
Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
Bachtiar, V., Kelly, M. D., Wilman, H. R., Jacobs, J., Newbould, R., Kelly, C. J., Gyngell, M. L., Groves, K. E., McKay, A., Herlihy, A. H., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214921 · Cited by 117
Self-citationMulti-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
Dennis, A., Cuthbertson, D. J., Wootton, D. G., Crooks, M. G., Gabbay, M., Eichert, N., Mouchti, S., Pansini, M., Roca‐Fernández, A., Thomaides-Brears, H. B., et al. (2023) · Journal of the Royal Society of Medicine · doi:10.1177/01410768231154703 · Cited by 117
Self-citationMojtahed, A., Kelly, M., Herlihy, A. H., Kin, S., Wilman, H. R., McKay, A., Kelly, M., Milanesi, M., Neubauer, S., Thomas, E. L., et al. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1701-2 · Cited by 109
Self-citationJi, Y., Yiorkas, A. M., Frau, F., Mook-Kanamori, D., Staiger, H., Thomas, E. L., Atabaki-Pasdar, N., Campbell, A., Tyrrell, J., Jones, S. E., et al. (2019) · Diabetes · doi:10.2337/db18-0708 · Cited by 99
Self-citationAtabaki-Pasdar, N., Ohlsson, M., Viñuela, A., Frau, F., Pomares-Millan, H., Haid, M., Jones, A. G., Thomas, E. L., Koivula, R. W., Kurbasic, A., et al. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003149 · Cited by 97
“The same protocol and procedure have been used to quantify MRI-derived liver fat in IMI DIRECT and UK Biobank [18].”
MethodInfluentialSelf-citationHe, P., Zhang, Y., Ye, Z., Li, H., Liu, M., Zhou, C., Yang, S., Gan, X., Zhang, Y., & Qin, X. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155643 · Cited by 100
Jaubert, O., Arrieta, C., da Cruz, G. J. L., Bustin, A., Schneider, T., Georgiopoulos, G. A., Masci, P. G., Sing‐Long, C., Botnar, R. M., & Prieto, C. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28311 · Cited by 95
Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
Schaapman, J. J., Tushuizen, M. E., Coenraad, M. J., & Lamb, H. J. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27292 · Cited by 85
McDonald, N., Eddowes, P. J., Hodson, J., Semple, S. I. K., Davies, N. P., Kelly, C. J., Kin, S., Phillips, M., Herlihy, A. H., Kendall, T. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27560-5 · Cited by 76
Self-citationMulti-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants
McCracken, C., Raisi‐Estabragh, Z., Veldsman, M., Raman, B., Dennis, A., Husain, M., Nichols, T. E., Petersen, S. E., & Neubauer, S. (2022) · Nature Communications · doi:10.1038/s41467-022-35321-2 · Cited by 80
Self-citationCastellino, G., Nikolić, D., Magán‐Fernández, A., Malfa, G. A., Chianetta, R., Patti, A. M., Amato, A., Montalto, G., Toth, P. P., Banach, M., et al. (2019) · Nutrients · doi:10.3390/nu11112580 · Cited by 63
An, U., Pazokitoroudi, A., Alvarez, M., Huang, L., Bacanu, S., Schork, A. J., Kendler, K. S., Pajukanta, P., Flint, J., Zaitlen, N., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01558-w · Cited by 74
Imajo, K., Tetlow, L. A., Dennis, A., Shumbayawonda, E., Mouchti, S., Kendall, T. J., Fryer, E., Yamanaka, S., Honda, Y., Kessoku, T., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i7.609 · Cited by 62
Self-citation21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
Neeland, I. J., Yokoo, T., Leinhard, O. D., & Lavie, C. J. (2021) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2020.02.031 · Cited by 53
Measurement of liver iron by magnetic resonance imaging in the UK Biobank population
McKay, A., Wilman, H. R., Dennis, A., Kelly, M., Gyngell, M. L., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209340 · Cited by 58
Self-citationFresneda, S., Abbate, M., Busquets-Cortés, C., López‐González, Á. A., Fuster-Parra, P., Bennasar‐Veny, M., & Yáñez, A. M. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00475-7 · Cited by 57
Chen, V. L., Du, X., Oliveri, A., Chen, Y., Kuppa, A., Halligan, B. D., Province, M. A., & Speliotes, E. K. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.045 · Cited by 55
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Thomaides-Brears, H. B., Lepe, R., Banerjee, R., & Duncker, C. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02684-3 · Cited by 52
Self-citationPlant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease
Lv, Y., Rong, S., Deng, Y., Bao, W., Xia, Y., & Chen, L. (2023) · BMC Medicine · doi:10.1186/s12916-023-03028-w · Cited by 59
Coffey, S., Lewandowski, A. J., Garratt, S., Meijer, R., Lynum, S., Bedi, R., Paterson, J., Yaqub, M., Noble, J. A., Neubauer, S., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317732273 · Cited by 48
Self-citationOmega-3 intake is associated with liver disease protection
Vell, M. S., Creasy, K. T., Scorletti, E., Seeling, K. S., Hehl, L., Rendel, M. D., Schneider, K. M., & Schneider, C. V. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1192099 · Cited by 42
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
Lind, L., Johansson, L., Ahlström, H. K., Eriksson, J. W., Larsson, A. O., Risérus, U., Kullberg, J., & Oscarsson, J. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i4.149 · Cited by 41
Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity
Arndtz, K., Shumbayawonda, E., Hodson, J. A., Eddowes, P. J., Dennis, A., Thomaides-Brears, H. B., Mouchti, S., Kelly, M., Banerjee, R., Neubauer, S., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1687 · Cited by 41
Self-citationSharma, D., Gotlieb, N., Farkouh, M. E., Patel, K., Xu, W., & Bhat, M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022576 · Cited by 36
“29 MRI-derived proton density fat fraction (MRI-PDFF) is a method that quantifies hepatic steatosis with a high degree of accuracy and is considered a well-validated diagnostic tool that is not significantly impacted by demographics, histologic activity, or coexisting hepatic conditions.”
Non-alcoholic fatty liver disease in Africa: a hidden danger
Paruk, I. M., Pirie, F. J., & Motala, A. A. (2019) · Global Health · doi:10.1017/gheg.2019.2 · Cited by 37
Validation of a standardized MRI method for liver fat and T2* quantification
Hutton, C., Gyngell, M. L., Milanesi, M., Bagur, A. T., & Brady, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204175 · Cited by 32
Self-citationA new era for steatotic liver disease: Evaluating the novel nomenclature in the UK Biobank
Schneider, K. M., & Schneider, C. V. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.007 · Cited by 33
Εvangelou, Ε., Suzuki, H., Bai, W., Pazoki, R., Gao, H., Matthews, P. M., & Elliott, P. (2021) · eLife · doi:10.7554/elife.65325 · Cited by 37
Self-citationLarge-scale biometry with interpretable neural network regression on UK Biobank body MRI
Langner, T., Strand, R., Ahlström, H. K., & Kullberg, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74633-5 · Cited by 32
Bell, W., Jennings, A., Thompson, A. S., Bondonno, N. P., Tresserra‐Rimbau, A., Kuhn, T. E., & Cassidy, A. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.09.022 · Cited by 31
Waddell, T., Bagur, A. T., Cunha, D., Thomaides-Brears, H. B., Banerjee, R., Cuthbertson, D. J., Brown, E. E., Cusi, K. J., Després, J., & Brady, M. (2022) · Obesity · doi:10.1002/oby.23425 · Cited by 30
Self-citationLiu, M., Ye, Z., Zhang, Y., He, P., Zhou, C., Yang, S., Zhang, Y., Gan, X., & Qin, X. (2024) · BMC Medicine · doi:10.1186/s12916-024-03618-2 · Cited by 30
Abbas, S. H., Ceresa, C. D. L., Hodson, L., Nasralla, D., Watson, C. J. E., Mergental, H., Coussios, C. C., Kaloyirou, F., Brusby, K., Mora, A., et al. (2024) · Trials · doi:10.1186/s13063-024-08189-4 · Cited by 30
The association between telomere length and non-alcoholic fatty liver disease: a prospective study
Tang, L., Li, D., Ma, Y., Cui, F., Wang, J., & Tian, Y. (2023) · BMC Medicine · doi:10.1186/s12916-023-03136-7 · Cited by 31
Chahal, D., Sharma, D., Keshavarzi, S., Arisar, F. A. Q., Patel, K., Xu, W., & Bhat, M. (2022) · Hepatology International · doi:10.1007/s12072-022-10304-z · Cited by 27
Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment
Irving, B., Hutton, C., Dennis, A., Vikal, S., Mavar, M., Kelly, M., & Brady, J. M. (2017) · Communications in computer and information science · doi:10.1007/978-3-319-60964-5_58 · Cited by 28
Self-citationShumbayawonda, E., French, M., Carolan, J. E., Beyer, C., Lorgelly, P. K., Tonev, D., Banerjee, R., Miller, M. H., Byrne, C. D., Patel, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00796-9 · Cited by 25
Self-citationSherry, A. P., Willis, S. A., Yates, T., Johnson, W., Razieh, C., Sargeant, J. A., Malaikah, S., Stensel, D. J., Aithal, G. P., & King, J. A. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2022.100622 · Cited by 22
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
Mancini, M., Summers, P. E., Faita, F., Brunetto, M. R., Callea, F., Nicola, A. D., Lascio, N. D., Farinati, F., Gastaldelli, A., Gridelli, B. G., et al. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i2.231 · Cited by 24
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank
Jamialahmadi, O., Tavaglione, F., Rawshani, A., Ljungman, C. E. A., & Romeo, S. (2023) · Liver International · doi:10.1111/liv.15556 · Cited by 23
Ho, B., Thompson, A., Jorgensen, A., & Pirmohamed, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100896 · Cited by 27
Aimuzi, R., Xie, Z., Qu, Y., Luo, K., & Jiang, Y. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.177529 · Cited by 24
Longitudinal analysis of risk of non‐alcoholic fatty liver disease in adulthood
Cuthbertson, D. J., Brown, E. E., Koskinen, J. M., Magnussen, C. G., Hutri‐Kähönen, N., Sabin, M. A., Tossavainen, P. H., Jokinen, E. V., Laitinen, T. P., Viikari, J. S. A., et al. (2018) · Liver International · doi:10.1111/liv.13993 · Cited by 23
Maidstone, R. J., Rutter, M. K., Marjot, T., Ray, D. W., & Baxter, M. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0472 · Cited by 27
Perry, A., Hadad, N., Chatterjee, E., Ramos, M. J., Farber‐Eger, E. H., Roshani, R., Stolze, L. K., Betti, M. J., Zhao, S., Huang, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101871 · Cited by 23
Hoy, A. M., McDonald, N., Lennen, R. J., Milanesi, M., Herlihy, A. H., Kendall, T. J., Mungall, W., Gyngell, M. L., Banerjee, R., Janiczek, R. L., et al. (2018) · Biology Open · doi:10.1242/bio.033910 · Cited by 21
Self-citationTian, A., Sun, Z., Zhang, M., Li, J., Pan, X., & Chen, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1117626 · Cited by 20
Machann, J., Hasenbalg, M., Dienes, J., Wagner, R. J., Sandforth, A., Fritz, V., Birkenfeld, A. L., Nikolaou, K., Kullmann, S., Schick, F., et al. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28084 · Cited by 19
Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content
Li, Y., van den Berg, E. H., Kurilshikov, A., Zhernakova, D. V., Gaćeša, R., Hu, S., Lopera-Maya, E. A., Zhernakova, A., Study, L. C., Aguirre‐Gamboa, R., et al. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae031 · Cited by 17
Ethnic Differences in Body Fat Deposition and Liver Fat Content in Two UK‐Based Cohorts
Alenaini, W., Parkinson, J. R. C., McCarthy, J. P., Goldstone, A. P., Wilman, H. R., Banerjee, R., Yaghootkar, H., Bell, J. D., & Thomas, E. L. (2020) · Obesity · doi:10.1002/oby.22948 · Cited by 17
Self-citationSandby, K., Geiker, N. R. W., Dalamaga, Μ., Grønbæk, H., & Magkos, F. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00430-4 · Cited by 17
Boncan, D. A. T., Yu, Y., Zhang, M., Lian, J., & Vardhanabhuti, V. (2024) · npj Aging · doi:10.1038/s41514-023-00127-z · Cited by 17
Uncertainty-aware body composition analysis with deep regression ensembles on UK Biobank MRI
Langner, T., Gustafsson, F., Avelin, B., Strand, R., Ahlström, H. K., & Kullberg, J. (2021) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2021.101994 · Cited by 19
Winterton, A., Bettella, F., Beck, D., Gurholt, T. P., Steen, N. E., Rødevand, L. N., Westlye, L. T., Andreassen, O. A., & Quintana, D. S. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105875 · Cited by 15
Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease
Gagnon, É., Manikpurage, H. D., Mitchell, P. L., Girard, A. S., Gobeil, É., Bourgault, J., Bégin, F., Marette, A., Thériault, S., & Arsenault, B. J. (2023) · iScience · doi:10.1016/j.isci.2023.107127 · Cited by 17
Aspirin is associated with a reduced incidence of liver disease in men
Vell, M. S., Krishnan, A., Wangensteen, K. J., Serper, M., Seeling, K. S., Hehl, L., Rendel, M. D., Zandvakili, I., Vujković, M., Scorletti, E., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000268 · Cited by 14
Roca‐Fernández, A., Dennis, A., Nicolls, R., McGonigle, J., Kelly, M., & Banerjee, R. (2020) · medRxiv · doi:10.1101/2020.06.04.20122457 · Cited by 16
Self-citationFan, H. X., Kouvari, M., Mingrone, G., George, J., Papatheodoridis, G., Valenzuela‐Vallejo, L., Liu, Z., Chen, X., Zhang, T., & Mantzoros, C. S. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.018 · Cited by 14
Obesity and Nonalcoholic Fatty Liver Disease
Bullón‐Vela, V., Abete, I., Martínez, J. A., & Zulet, M. Á. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00006-4 · Cited by 22
Mchenry, S. A., Park, Y., & Davidson, N. O. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.035 · Cited by 12
Metabolic profiling of MRI ‐measured liver fat in the UK Biobank
Gnatiuc, L., Trichia, E., Aguilar-Ramirez, D. J., & Preiss, D. (2023) · Obesity · doi:10.1002/oby.23687 · Cited by 11
Sandby, K., Krarup, T., Chabanova, E., Geiker, N. R. W., & Magkos, F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae572 · Cited by 11
Wang, H., Zheng, C., & Wang, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-91221-7 · Cited by 11
James, L., Diamond, C., Al‐Mossawi, H., Andersson, A., Pandya, P., Shumbayawonda, E., Firouzabadi, L. I., Watson, L., Savage, L. J., Thomaides-Brears, H. B., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf344 · Cited by 13
Self-citationBjörnson, E., Adiels, M., Bergström, G. M. L., & Gummesson, A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117397 · Cited by 11
MIMIR: Deep Regression for Automated Analysis of UK Biobank MRI Scans
Langner, T., Mora, A. M., Strand, R., Ahlström, H. K., & Kullberg, J. (2022) · Radiology Artificial Intelligence · doi:10.1148/ryai.210178 · Cited by 12
Genome-wide association study of liver fat, iron, and extracellular fluid fraction in the UK BiobankPreprint
O’Dushlaine, C. T., Germino, M., Verweij, N., Nielsen, J. B., Yadav, A. K., Benner, C., Backman, J., Lin, N., Abecasis, G. R., Baras, A., et al. (2021) · medRxiv · doi:10.1101/2021.10.25.21265127 · Cited by 11
Fan, W., Yang, S., Wei, Y., Tian, M., Liu, Q., Li, X., Ding, J., Li, X., Mao, M., Han, X., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16362 · Cited by 9
Adding salt to foods increases the risk of metabolic dysfunction-associated steatotic liver disease
Chen, H., Zhang, X., Lin, S., & Wu, Q. (2025) · Communications Medicine · doi:10.1038/s43856-025-01074-4 · Cited by 9
Chen, S., Pang, J., Huang, R., You, Y., Zhang, H., Xue, H., & Chen, X. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad346 · Cited by 12
The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis
Weiskirchen, R., & Tacke, F. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0421-y · Cited by 9
Large-Scale Inference of Liver Fat with Neural Networks on UK Biobank Body MRI
Langner, T., Strand, R., Ahlström, H. K., & Kullberg, J. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-59713-9_58 · Cited by 11
Asaturyan, H. A., Basty, N., Thanaj, M., Whitcher, B. J., Thomas, E. L., & Bell, J. D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273171 · Cited by 10
Self-citationLiver shape analysis using statistical parametric maps at population scale
Thanaj, M., Basty, N., Cule, M., Sorokin, E. P., Whitcher, B. J., Bell, J. D., & Thomas, E. L. (2024) · BMC Medical Imaging · doi:10.1186/s12880-023-01149-5 · Cited by 9
Self-citationXiao, Y., Xu, S., Hu, W., Huang, J., Jiang, D., Na, R., Yin, Z., Zhang, J., & Chen, H. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101750 · Cited by 8
Seidelin, A.-S., Nordestgaard, B. G., Tybjærg‐Hansen, A., Yaghootkar, H., & Stender, S. (2022) · Hepatology International · doi:10.1007/s12072-022-10331-w · Cited by 9
Wachinger, C., Wolf, T. N., & Pölsterl, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22239 · Cited by 9
Winther‐Sørensen, M., García, S. L., Bartholdy, A., Ottenheijm, M. E., Banasik, K., Brunak, S., Sørensen, C. M., Gluud, L. L., Knop, F. K., Holst, J. J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06160-1 · Cited by 8
Tavaglione, F., Marafioti, G., Romeo, S., & Jamialahmadi, O. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae371 · Cited by 9
Zalejska–Fiolka, J., Birková, A., Hubková, B., Wielkoszyński, T., Čižmárová, B., Szlachta, B., Fiolka, R., Błaszczyk, U., Wylęgała, A., Kasperczyk, S., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109021 · Cited by 8
Correction: Characterisation of liver fat in the UK Biobank cohort
Wilman, H., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A. H., Gyngell, M. L., Neubauer, S., Bell, J. D., Banerjee, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176867 · Cited by 8
Self-citationSomineni, H., Mukherjee, S., Amar, D., Pei, J., Guo, K., Light, D., Flynn, K. J., Probert, C. S., Soare, T. W., Satapati, S., et al. (2024) · medRxiv · doi:10.1101/2024.01.06.24300923 · Cited by 9
Jiang, J., Liu, Y., Yang, H., Ma, Z., Liu, W., Zhao, M., Peng, X., Qin, X., & Yang, X. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116497 · Cited by 8
Zhang, S., Huo, Z., Borné, Y., Sonestedt, E., & Li, X. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03745-3 · Cited by 7
Feng, Q., Manousou, P., Izzi‐Engbeaya, C. N., Loomba, R. S., Thursz, M. R., & Woodward, M. (2025) · Liver International · doi:10.1111/liv.70485 · Cited by 10
Nabi, O., Spaak, J., Bergström, G. M. L., Engström, G., Östgren, C. J., Malinovschi, A., Kullberg, J., Blomberg, A., Jernberg, T., Andersson, D. P., et al. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70071 · Cited by 6
Metadata
- Authors
- Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L.
- Affiliations
- Perspectum Ltd. (United Kingdom) (GB)
- UK Biobank (GB)
- Imperial College London (GB)
- University of Oxford (GB)
- University of Westminster (GB)
- Corresponding author
- Thomas, E. Louise
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 2
- Pages
- e0172921
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5328634
- OpenAlex
- W2592225941
- Semantic Scholar
- dd6e2426ed5f28051c4cc16156363c47f4aa0135
- Cited by
- 159
- References
- 37
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 28 · 2023: 23 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 5 · 2018: 13 · 2017: 4
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-04-26)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Innovate UK (GB) (010271)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- liver fat, non-alcoholic fatty liver disease, proton density fat fraction, magnetic resonance imaging, UK Biobank, body mass index, type 2 diabetes, blood pressure, weight gain, mass screening, risk factors
- MeSH terms
- Adipose Tissue, Age Factors, Aged, Cross-Sectional Studies, Female, United Kingdom, Humans, Image Processing, Computer-Assisted, Liver, Liver Diseases, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Prospective Studies, Risk Factors, Body Mass Index, Treatment Outcome, Biological Specimen Banks, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.